A Study To Asses Mass Balance And Absolute Bioavailability Of 14C PF-06826647 In Healthy Male Participants

NCT04591262 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: 14C-PF-06826647-LR 600 mg PO
DRUG: PF-06826647 600 mg PO
DRUG: 14C-PF-06826647 100 ug IV

Sponsor

Pfizer